Efficacy and safety evaluation of pregabalin treatment over 52 weeks in patients with diabetic neuropathic pain extended after a double‐blind placebo‐controlled trial

Aims/Introduction:  Diabetic peripheral neuropathy (DPN) is often associated with pain, and thus a new treatment option is anticipated. We recently showed the efficacy of pregabalin in a randomized, double‐blind, placebo‐controlled, 14‐week trial in Japanese patients with painful DPN. In the present...

Descripción completa

Detalles Bibliográficos
Autores principales: Satoh, Jo, Yagihashi, Soroku, Baba, Masayuki, Suzuki, Makoto, Arakawa, Akio, Yoshiyama, Tamotsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2011
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014905/
https://www.ncbi.nlm.nih.gov/pubmed/24843530
http://dx.doi.org/10.1111/j.2040-1124.2011.00122.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014905/
https://www.ncbi.nlm.nih.gov/pubmed/24843530
http://dx.doi.org/10.1111/j.2040-1124.2011.00122.x

Ejemplares similares